-
公开(公告)号:EP2998289B1
公开(公告)日:2019-08-07
申请号:EP15181729.3
申请日:2012-06-08
发明人: Sridhar, C. Nagarajan , Karmali, Priya , Payne, Joseph E. , Hou, Zheng , Gaudette, John A. , Knopov, Victor , Witte, Richard P. , Ahmadian, Mohammad , Perelman, Loren A. , Tanaka, Yasunobu , Akopian, Violetta , Niitsu, Yoshiro
IPC分类号: C07C237/08 , A61K31/16 , A61P1/16 , C07C237/22 , C07C323/60 , C07C333/04 , A61K9/127
-
公开(公告)号:EP3434773A3
公开(公告)日:2019-04-17
申请号:EP18191694.1
申请日:2010-12-08
发明人: Jin, Xiaomei , Yu, Lei , Takahashi, Hirokazu , Tanaka, Yasunobu , Niitsu, Yoshiro , Feinstein, Elena , Avkin-Nachum, Sharon , Kalinski, Hagar , Mett, Igor , Erlich, Shai , Squiers, Elizabeth, C. , Chen, Ning
IPC分类号: C12N15/113 , A61K31/713 , C07H21/02
摘要: Provided herein are compositions, methods and kits for modulating expression of target genes, particularly heat shock protein 47 (hsp47). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding hsp47, for example, the gene encoding human hsp47. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with hsp47 such as liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis.
-
公开(公告)号:EP3025731A1
公开(公告)日:2016-06-01
申请号:EP15202384.2
申请日:2009-03-16
发明人: Niitsu, Yoshiro , Takimoto, Rishu
IPC分类号: A61K47/10 , A61K9/127 , A61K31/7088 , A61K48/00 , A61P11/00
摘要: Disclosed are: a substance transfer carrier to an extracellular matrix-producing cell in the lung, which comprises a retinoid; a therapeutic agent for fibroid lung, which utilized the carrier; and a preparation kit of the therapeutic agent.
摘要翻译: 本发明公开了一种向肺内产生细胞外基质的细胞的物质转移载体,其包含类视色素; 一种利用载体的纤维瘤肺治疗剂; 和治疗剂的制备试剂盒。
-
公开(公告)号:EP2730277A2
公开(公告)日:2014-05-14
申请号:EP13193438.2
申请日:2005-12-22
发明人: Niitsu, Yoshiro , Kato, Junji , Sato, Yasushi
IPC分类号: A61K9/107 , A61K9/127 , A61K31/7088 , A61K31/07 , A61K45/06 , A61K9/50 , A61K9/51 , A61P1/16 , A61P1/18 , A61P43/00
摘要: A stellate cell-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, a stellate cell-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of stellate cells, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.
摘要翻译: 含有类维生素A衍生物和/或维生素A类似物作为成分的星状细胞特异性药物载体; 使用它的药物递送方法; 含有它的药物; 以及使用该药物的治疗方法。 通过将药物载体与类视黄醇衍生物如维生素A或维生素A类似物结合或将其包封在药物载体中,用于治疗用途的药物可以特异性递送至星形胶质细胞。 结果,可以有效地抑制或预防星状细胞相关疾病,同时使副作用最小化。 作为抑制星状细胞活性或生长的药物,例如,可以将针对作为胶原特异性分子伴侣的HSP47的siRNA包封在药物载体中。 因此,可以同时抑制I型向IV型胶原的分泌,进而可以有效抑制纤维化。
-
公开(公告)号:EP2730277B1
公开(公告)日:2020-03-11
申请号:EP13193438.2
申请日:2005-12-22
发明人: Niitsu, Yoshiro , Kato, Junji , Sato, Yasushi
-
公开(公告)号:EP3050965B1
公开(公告)日:2018-05-23
申请号:EP16155975.2
申请日:2009-09-04
发明人: Niitsu, Yoshiro , Matsunaga, Takuya
IPC分类号: C12N15/113 , A61K31/07 , A61K47/54 , A61K9/127
CPC分类号: C12N15/113 , A61K9/1272 , A61K31/07 , A61K31/7105 , A61K45/06 , A61K47/551 , A61K47/6911 , C12N15/111 , C12N2310/14 , C12N2320/32 , A61K2300/00
摘要: Disclosed is a substance delivery carrier for an extracellular-matrix-producing cell in the bone marrow, which comprises a retinoid. Also disclosed is an agent for treating myelofibrosis by utilizing a substance capable of regulating the activity or proliferation of an extracellular-matrix-producing cell in the bone marrow.
-
公开(公告)号:EP2727583A3
公开(公告)日:2014-07-23
申请号:EP13189691.2
申请日:2005-12-22
发明人: Niitsu, Yoshiro , Kato, Junji , Sato, Yasushi
IPC分类号: A61K9/107 , A61K9/127 , A61K31/7088 , A61K31/07 , A61K45/06 , A61K9/50 , A61K9/51 , A61P1/16 , A61P1/18 , A61P43/00 , A61K47/48
CPC分类号: A61K31/07 , A61K9/0019 , A61K9/127 , A61K9/14 , A61K31/7088 , A61K38/1833 , A61K38/1841 , A61K38/1858 , A61K45/06 , A61K47/6911 , Y10S514/893 , Y10T428/2982 , A61K2300/00
摘要: A stellate cell-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, a stellate cell-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of stellate cells, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.
-
公开(公告)号:EP4005601A1
公开(公告)日:2022-06-01
申请号:EP21207976.8
申请日:2005-12-22
发明人: Niitsu, Yoshiro , Kato, Junji , Sato, Yasushi
IPC分类号: A61K47/69 , A61K47/10 , A61K9/00 , A61K9/107 , A61K9/127 , A61K9/50 , A61K9/51 , A61K31/07 , A61K31/7088 , A61K45/00 , A61K45/06 , A61K47/14 , A61K48/00 , A61P1/16 , A61P1/18 , A61P43/00
摘要: A stellate cell-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, a stellate cell-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of stellate cells, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.
-
公开(公告)号:EP3050965A1
公开(公告)日:2016-08-03
申请号:EP16155975.2
申请日:2009-09-04
发明人: Niitsu, Yoshiro , Matsunaga, Takuya
IPC分类号: C12N15/113 , C12N15/11 , A61K31/713 , A61K31/07
CPC分类号: C12N15/113 , A61K9/1272 , A61K31/07 , A61K31/7105 , A61K45/06 , A61K47/551 , A61K47/6911 , C12N15/111 , C12N2310/14 , C12N2320/32 , A61K2300/00
摘要: Disclosed is a substance delivery carrier for an extracellular-matrix-producing cell in the bone marrow, which comprises a retinoid. Also disclosed is an agent for treating myelofibrosis by utilizing a substance capable of regulating the activity or proliferation of an extracellular-matrix-producing cell in the bone marrow.
摘要翻译: 公开了骨髓中细胞外基质产生细胞的物质递送载体,其包含类视色素。 还公开了通过利用能够调节骨髓中细胞外基质产生细胞的活性或增殖的物质来治疗骨髓纤维化的药剂。
-
公开(公告)号:EP3012324A3
公开(公告)日:2016-07-06
申请号:EP15193839.6
申请日:2010-12-08
发明人: Jin, Xiaomei , Yu, Lei , Takahashi, Hirokazu , Tanaka, Yasunobu , Niitsu, Yoshiro , Feinstein, Elena , Avkin-Nachum, Sharon , Kalinski, Hagar , Mett, Igor , Erlich, Shai , Squiers, Elizabeth C. , Chen, Ning
IPC分类号: C12N15/113 , A61K31/713 , C07H21/02
CPC分类号: C12N15/113 , A61K31/713 , C12N2310/11 , C12N2310/14 , C12N2310/31 , C12N2310/315 , C12N2310/317 , C12N2310/32 , C12N2310/321 , C12N2310/33 , C12N2310/531 , C12N2320/30 , C12N2310/3521
摘要: Provided herein are compositions, methods and kits for modulating expression of target genes, particularly heat shock protein 47 (hsp47). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding hsp47, for example, the gene encoding human hsp47. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with hsp47 such as liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis.
摘要翻译: 本文提供用于调节靶基因,特别是热休克蛋白47(hsp47)的表达的组合物,方法和试剂盒。 组合物,方法和试剂盒可以包括核酸分子(例如,短干扰核酸(siNA),短干扰RNA(siRNA),双链RNA(dsRNA),微RNA(miRNA)或短发夹RNA(shRNA )),其调节编码hsp47的基因,例如编码人hsp47的基因。 本文公开的组合物和方法也可用于治疗与hsp47相关的病症和病症,例如肝纤维化,肺纤维化,腹膜纤维化和肾纤维化。
-
-
-
-
-
-
-
-
-